Medtronic Recalls Harmony Catheter System Over Tip Detachment Risk
MDT is trading near its 52-week low of $73.31 (14% above the low) on light trading volume (0.3× avg).
Summary
The FDA announced Medtronic is recalling its Harmony Delivery Catheter System due to a risk of the distal tip detaching during procedures. This is a Class I recall, the most serious type, indicating potential for serious injury or death. The Harmony system is used in minimally invasive heart valve procedures, a key growth area for Medtronic's structural heart portfolio. No injuries or deaths have been reported yet, but the recall could disrupt procedure volumes and invite regulatory scrutiny. Medtronic's recent strong Q4 results and FY2026 revenue of $36.36 billion provide some cushion, but this recall adds to existing legal headwinds, including a $1.1 billion antitrust verdict under appeal. Investors will watch for any financial impact or manufacturing delays in upcoming quarters.
At the time of this announcement, MDT was trading at $83.67 on NYSE in the Life Sciences sector, with a market capitalization of approximately $107.1B. The 52-week trading range was $73.31 to $106.33. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: Reuters.